Accelerating the development of a malaria vaccine for Africa

Malaria remains an internationally leading cause of ill health and poverty. There is no efficacious vaccine available, and recent progress in malaria control is jeopardized by drug resistance, failing insecticides, and inadequate health infrastructur ... First-year report: The project has three main objectives: Objective 1 will be pursued by the two project PhD students. Jennifer Suurbaar will focus on the development of ICAM-1/EPCR-binding PfEMP1 as vaccine candidate as described in the projec ...